Concepedia

Deborah Berg

DB

43

Publications

6K

Citations

28

H-Index

1953

Active since

Affiliations

Millennium Engineering and Integration (United States)(Current)

Dana-Farber Cancer Institute

Takeda (United States)

Mayo Clinic in Arizona

Emory University

Deborah Berg is an author at Millennium Engineering and Integration (United States) specializing in medicine, health sciences, and pharmacotherapy.

Top concepts

Publications per year

1953–2021

43

Publications

43

Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

Robert J. Mayer, Roger B. Davis, Charles A. Schiffer et al. · New England Journal of Medicine · 1994 · 1.4K citations · Full text

Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Philippe Moreau, Tamás Masszi, Norbert Grząśko et al. · New England Journal of Medicine · 2016 · 1K citations · Full text

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

Clara D. Bloomfield, David Lawrence, John C. Byrd et al. · PubMed · 1998 · 696 citations

, , +16

Granulocyte–Macrophage Colony-Stimulating Factor after Initial Chemotherapy for Elderly Patients with Primary Acute Myelogenous Leukemia

Richard M. Stone, Deborah Berg, Stephen L. George et al. · New England Journal of Medicine · 1995 · 451 citations · Full text

Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study

Shaji Kumar, Jesús G. Berdeja, Rubén Niesvizky et al. · The Lancet Oncology · 2014 · 260 citations

, , +10

Rows per page

1–5 of 43